Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;33(2):197-208.
doi: 10.1016/j.ccl.2015.02.002.

Lipoprotein apheresis

Patrick M Moriarty  1 , Linda Hemphill  2
Affiliations
Review

Lipoprotein apheresis

Patrick M Moriarty et al. Cardiol Clin. 2015 May.

Abstract

Patients with familial hypercholesterolemia (FH) have early development of atherosclerosis and cardiovascular disease (CVD). Lipid level-lowering medications are not always successful in reducing increased low-density lipoprotein C (LDL-C) levels. Lipoprotein apheresis (LA) therapy has proven its clinical benefit in reducing CVD events for patients with FH with hypercholesterolemia. LA reduces LDL-C levels by more than 60% in patients with FH and reduces CVD events. LA also reduces Lp(a) levels and CVD events. LA reduces inflammatory markers and blood viscosity.

Keywords: Atherosclerosis; CVD; Familial hypercholesterolemia; LDL-C; Lipoprotein apheresis; Lp(a).

PubMed Disclaimer

Republished in

  • Lipoprotein Apheresis.
    Moriarty PM, Hemphill L. Moriarty PM, et al. Endocrinol Metab Clin North Am. 2016 Mar;45(1):39-54. doi: 10.1016/j.ecl.2015.09.003. Endocrinol Metab Clin North Am. 2016. PMID: 26892996 Review.

MeSH terms